Health companies have large cash reserves, and drugmakers are shifting their focus from cost-cutting to filling pipelines through mergers and acquisitions, industry analysts say. Next year could top the 2,076 health deals worth $166 billion announced in the past 12 months. "What tends to drive that is the need. There's clearly a need for larger companies who are facing patent cliffs and whose own R&D machines have not panned out, to find growth," he said.
Health M&A could increase in 2013, analysts say
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||